Professor Karla Arruda and Professor Marcus Maurer discuss the development and implementation of UCARE in Brazil, and its potential benefits for individuals suffering from chronic spontaneous urticaria (CSU). The conversation extends towards exploring the framework of the Brazilian UCARE centres and projects, and how it can be implemented in other countries. Professor Maurer delves into the clinical efficacy, advantages, and impact on patient quality of life of utilising Bruton’s tyrosine kinase inhibitors for the treatment of CSU, along with further discussion of alternative treatments. Access additional resources by signing up to Medthority and to be notified for future ‘All Things Urticaria’ podcast episodes!
Read more news regarding urticaria
Journal Club,News
May 26, 2023Dear all, coming Thursday, the UCARE Journal Club will be held by Ceyda Çaytemel from Cam Sakura UCARE Center on: Çaytemel C, Türkoğlu Z, Ağırgöl Ş, Ustaoğlu E, Demir FT, [...]
News
May 19, 2023Dr. Marcus Maurer recently visited Seoul (South Korea) to attend the KAAACI International Congress, where he spoke at the Novartis Korea Luncheon symposium on "Advances in CSU Treatment Optimization: Yesterday, [...]
News
May 19, 2023We are happy to have gained Seoul National University Hospital in South Korea for the UCARE network. Please see some impressions of the audit below.
